dc.contributor.author | ERDOGAN, A. | |
dc.contributor.author | ERAKSOY, MEFKÜRE | |
dc.contributor.author | Tuezuen, Erdem | |
dc.contributor.author | YAPICI, Zühal | |
dc.contributor.author | ALTUNAYOGLU, V. | |
dc.date.accessioned | 2021-03-03T11:23:06Z | |
dc.date.available | 2021-03-03T11:23:06Z | |
dc.date.issued | 2007 | |
dc.identifier.citation | YAPICI Z., Tuezuen E., ALTUNAYOGLU V., ERDOGAN A., ERAKSOY M., "High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis", INTERNATIONAL JOURNAL OF NEUROSCIENCE, cilt.117, sa.11, ss.1505-1512, 2007 | |
dc.identifier.issn | 0020-7454 | |
dc.identifier.other | av_279e333a-33f5-45e2-99ae-f2b32d567d7f | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/31490 | |
dc.identifier.uri | https://doi.org/10.1080/00207450601125840 | |
dc.description.abstract | To investigate the significance of humoral immunological factors in juvenile myasthenia gravis (JMG) patients, 11 children with JMG ( age of onset between 2 and 13 years) and 8 healthy controls were enrolled. Plasma IL-2, IL-10, IFN-gamma, TNF-alpha, complement factor C3, C4, and C1q levels were measured by ELISA. IL-2, IL-10, TNF-alpha, C3, and C4 levels were significantly elevated in the patient group. Moreover, plasma IL-10 levels were associated with the presence of anti-AChR antibody and response to treatment suggesting a critical role for IL-10 in JMG pathogenesis. | |
dc.language.iso | eng | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Temel Bilimler | |
dc.subject | NEUROSCIENCES | |
dc.subject | Sinirbilim ve Davranış | |
dc.subject | Yaşam Bilimleri | |
dc.title | High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis | |
dc.type | Makale | |
dc.relation.journal | INTERNATIONAL JOURNAL OF NEUROSCIENCE | |
dc.contributor.department | , , | |
dc.identifier.volume | 117 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 1505 | |
dc.identifier.endpage | 1512 | |
dc.contributor.firstauthorID | 2017 | |